331 related articles for article (PubMed ID: 23757426)
1. Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort.
Pop-Busui R; Lu J; Brooks MM; Albert S; Althouse AD; Escobedo J; Green J; Palumbo P; Perkins BA; Whitehouse F; Jones TL;
Diabetes Care; 2013 Oct; 36(10):3208-15. PubMed ID: 23757426
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.
Pop-Busui R; Lu J; Lopes N; Jones TL;
J Peripher Nerv Syst; 2009 Mar; 14(1):1-13. PubMed ID: 19335534
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial.
Althouse AD; Abbott JD; Forker AD; Bertolet M; Barinas-Mitchell E; Thurston RC; Mulukutla S; Aboyans V; Brooks MM;
Diabetes Care; 2014; 37(5):1346-52. PubMed ID: 24595631
[TBL] [Abstract][Full Text] [Related]
4. Insulin provision therapy and mortality in older adults with diabetes mellitus and stable ischemic heart disease: Insights from BARI-2D trial.
Damluji AA; Cohen ER; Moscucci M; Myerburg RJ; Cohen MG; Brooks MM; Rich MW; Forman DE
Int J Cardiol; 2017 Aug; 241():35-40. PubMed ID: 28314486
[TBL] [Abstract][Full Text] [Related]
5. Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Althouse AD; Abbott JD; Sutton-Tyrrell K; Forker AD; Lombardero MS; Buitrón LV; Pena-Sing I; Tardif JC; Brooks MM;
Diabetes Care; 2013 Oct; 36(10):3269-75. PubMed ID: 23735723
[TBL] [Abstract][Full Text] [Related]
6. Determinants of successful glycemic control among participants in the BARI 2D trial: a post-hoc analysis.
Ismail-Beigi F; Lombardero MS; Escobedo J; Genuth S; Green J; Massaro E; Mooradian AD; Ovalle F; Whitehouse F; Zonszein J;
J Diabetes Complications; 2014; 28(1):101-9. PubMed ID: 23478173
[TBL] [Abstract][Full Text] [Related]
7. Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial.
Khan AA; Chung MJ; Novak E; Brown DL
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903941
[TBL] [Abstract][Full Text] [Related]
8. A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies.
Tang Y; Lenzini PA; Pop-Busui R; Ray PR; Campbell H; Perkins BA; Callaghan B; Wagner MJ; Motsinger-Reif AA; Buse JB; Price TJ; Mychaleckyj JC; Cresci S; Shah H; Doria A
Diabetes; 2019 Aug; 68(8):1649-1662. PubMed ID: 31127053
[TBL] [Abstract][Full Text] [Related]
9. Estimated glucose disposal rate predicts the risk of diabetic peripheral neuropathy in type 2 diabetes: A 5-year follow-up study.
Zhang Y; Sun W; Zhang Q; Bai Y; Ji L; Zheng H; Zhu X; Liu X; Zhang S; Xiong Q; Li Y; Chen L; Lu B
J Diabetes; 2024 May; 16(5):e13482. PubMed ID: 38225901
[TBL] [Abstract][Full Text] [Related]
10. Strategies for glycemic control in nonobese and obese type 2 diabetic patients with coronary artery disease.
Tsujimoto T; Kajio H
Int J Cardiol; 2019 May; 282():1-6. PubMed ID: 30772014
[TBL] [Abstract][Full Text] [Related]
11. Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients.
Hu YM; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ; Guo AS; Li JA; Su JB
Endocrine; 2018 May; 60(2):292-300. PubMed ID: 29411305
[TBL] [Abstract][Full Text] [Related]
12. Diabetic peripheral neuropathy: age-stratified glycemic control.
Wang CS; Pai YW; Lin CH; Lee IT; Chen HH; Chang MH
Front Endocrinol (Lausanne); 2024; 15():1377923. PubMed ID: 38694945
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial.
Wolk R; Bertolet M; Brooks MM; Pratley RE; Sobel BE; Frye RL; Singh P; Calvin AD; Rutter MK; Mooradian AD; Somers VK;
Eur J Prev Cardiol; 2016 Jan; 23(1):50-8. PubMed ID: 25073857
[TBL] [Abstract][Full Text] [Related]
15. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease.
Mayeda L; Katz R; Ahmad I; Bansal N; Batacchi Z; Hirsch IB; Robinson N; Trence DL; Zelnick L; de Boer IH
BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958307
[TBL] [Abstract][Full Text] [Related]
16. The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes).
Chung SC; Hlatky MA; Faxon D; Ramanathan K; Adler D; Mooradian A; Rihal C; Stone RA; Bromberger JT; Kelsey SF; Brooks MM;
J Am Coll Cardiol; 2011 Aug; 58(8):810-9. PubMed ID: 21835316
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study.
Jaiswal M; Divers J; Dabelea D; Isom S; Bell RA; Martin CL; Pettitt DJ; Saydah S; Pihoker C; Standiford DA; Dolan LM; Marcovina S; Linder B; Liese AD; Pop-Busui R; Feldman EL
Diabetes Care; 2017 Sep; 40(9):1226-1232. PubMed ID: 28674076
[TBL] [Abstract][Full Text] [Related]
18. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group
Am Heart J; 2008 Sep; 156(3):528-536, 536.e1-5. PubMed ID: 18760137
[TBL] [Abstract][Full Text] [Related]
19. The Eurodiab study: what has this taught us about diabetic peripheral neuropathy?
Tesfaye S; Selvarajah D
Curr Diab Rep; 2009 Dec; 9(6):432-4. PubMed ID: 19954687
[TBL] [Abstract][Full Text] [Related]
20. Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial.
Hansen CS; Lundby-Christiansen L; Tarnow L; Gluud C; Hedetoft C; Thorsteinsson B; Hemmingsen B; Wiinberg N; Sneppen SB; Lund SS; Krarup T; Madsbad S; Almdal T; Carstensen B; Jørgensen ME;
Cardiovasc Diabetol; 2020 Sep; 19(1):150. PubMed ID: 32979921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
